Ophthalmic Devices - Sweden

  • Sweden
  • The projected revenue in the Ophthalmic Devices market market in Sweden is estimated to reach US$130.70m in 2024.
  • It is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 4.23%, leading to a market volume of US$160.80m by 2029.
  • In comparison to other countries, the United States is expected to generate the highest revenue in this market, reaching US$14,000.00m in 2024.
  • The demand for advanced ophthalmic devices in Sweden is driven by the country's high healthcare standards and emphasis on research and development in the medical technology sector.

Key regions: Germany, Italy, France, Japan, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Ophthalmic Devices market in Sweden is experiencing significant growth due to several factors. Customer preferences in Sweden are driving the demand for advanced ophthalmic devices, while local special circumstances and underlying macroeconomic factors are contributing to the overall development of the market. Customer preferences in Sweden are increasingly focused on high-quality and technologically advanced ophthalmic devices. As a country known for its innovation and technological advancements, Swedish consumers have high expectations when it comes to healthcare products. This includes ophthalmic devices such as diagnostic equipment, surgical instruments, and vision correction devices. Customers in Sweden are willing to invest in cutting-edge technologies that offer improved accuracy, precision, and patient comfort. This preference for advanced ophthalmic devices is driving the growth of the market in Sweden. Trends in the market reflect the increasing demand for ophthalmic devices in Sweden. One key trend is the rising adoption of minimally invasive surgical techniques. Swedish healthcare providers are increasingly opting for less invasive procedures that offer faster recovery times and reduced risks for patients. This has led to a growing demand for ophthalmic devices that enable minimally invasive surgeries, such as micro-incision cataract surgery and laser-assisted vision correction. The market is also witnessing a trend towards personalized ophthalmic devices, as patients seek customized solutions for their specific vision needs. Local special circumstances in Sweden are also contributing to the development of the Ophthalmic Devices market. The country has a well-established healthcare system that provides universal access to healthcare services. This ensures that a large portion of the population has access to ophthalmic care, leading to a higher demand for ophthalmic devices. Additionally, Sweden has a high prevalence of certain eye conditions, such as myopia and age-related macular degeneration, which further drives the demand for ophthalmic devices. Underlying macroeconomic factors are also playing a role in the growth of the Ophthalmic Devices market in Sweden. The country has a strong economy and a high standard of living, which allows individuals to invest in their healthcare and prioritize their vision health. Additionally, the aging population in Sweden is leading to an increased demand for ophthalmic devices, as age-related eye conditions become more prevalent. The government's focus on healthcare and investments in medical research and development also contribute to the growth of the market. In conclusion, the Ophthalmic Devices market in Sweden is experiencing significant growth due to customer preferences for advanced devices, local special circumstances, and underlying macroeconomic factors. The market is witnessing trends towards minimally invasive surgeries and personalized devices, reflecting the demands of Swedish consumers. With a well-established healthcare system and a strong economy, Sweden provides a favorable environment for the development of the Ophthalmic Devices market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)